SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
While the Obama administration's getting serious about healthcare reform, it's time for a rather pointed reading comprehension test.
Consider the following story and find, if you can, the obvious problem:
The Swiss drug company Novartis will not give free vaccines against H1N1 flu to poor countries -- it will only consider discounts.
Novartis's refusal comes in the wake of a request from the Director General of the World Health Organization, Dr. Margaret Chan, who has called for drug companies to show solidarity with poor countries as they develop vaccines against the H1NI or "swine flu" pandemic.
Just by way of reminder, H1N1 has infected around 30,000 people globally, mostly in North America, though there have been a few deaths outside Mexico and the United States. Europe suffered its first death on Sunday. The first has just been reported in Argentina.
Help the poor prevent a pandemic? Novartis said 'No'. That's Novartis --makers of Exedrin and Bufferin -- I guess they haven't made enough off those over-the-counter best-sellers.
"If you want to make production sustainable, you have to create financial incentives," explained Novartis Chief Executive Daniel Vasella.
By "financial incentives" he means the 'p' word: profits.
Spot the flaw in the profit-driven approach to health care? Anyone?
Financial incentives?
When a pandemic isn't incentive enough -- I'd say we have another 'p' word -- a problem.
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
While the Obama administration's getting serious about healthcare reform, it's time for a rather pointed reading comprehension test.
Consider the following story and find, if you can, the obvious problem:
The Swiss drug company Novartis will not give free vaccines against H1N1 flu to poor countries -- it will only consider discounts.
Novartis's refusal comes in the wake of a request from the Director General of the World Health Organization, Dr. Margaret Chan, who has called for drug companies to show solidarity with poor countries as they develop vaccines against the H1NI or "swine flu" pandemic.
Just by way of reminder, H1N1 has infected around 30,000 people globally, mostly in North America, though there have been a few deaths outside Mexico and the United States. Europe suffered its first death on Sunday. The first has just been reported in Argentina.
Help the poor prevent a pandemic? Novartis said 'No'. That's Novartis --makers of Exedrin and Bufferin -- I guess they haven't made enough off those over-the-counter best-sellers.
"If you want to make production sustainable, you have to create financial incentives," explained Novartis Chief Executive Daniel Vasella.
By "financial incentives" he means the 'p' word: profits.
Spot the flaw in the profit-driven approach to health care? Anyone?
Financial incentives?
When a pandemic isn't incentive enough -- I'd say we have another 'p' word -- a problem.
While the Obama administration's getting serious about healthcare reform, it's time for a rather pointed reading comprehension test.
Consider the following story and find, if you can, the obvious problem:
The Swiss drug company Novartis will not give free vaccines against H1N1 flu to poor countries -- it will only consider discounts.
Novartis's refusal comes in the wake of a request from the Director General of the World Health Organization, Dr. Margaret Chan, who has called for drug companies to show solidarity with poor countries as they develop vaccines against the H1NI or "swine flu" pandemic.
Just by way of reminder, H1N1 has infected around 30,000 people globally, mostly in North America, though there have been a few deaths outside Mexico and the United States. Europe suffered its first death on Sunday. The first has just been reported in Argentina.
Help the poor prevent a pandemic? Novartis said 'No'. That's Novartis --makers of Exedrin and Bufferin -- I guess they haven't made enough off those over-the-counter best-sellers.
"If you want to make production sustainable, you have to create financial incentives," explained Novartis Chief Executive Daniel Vasella.
By "financial incentives" he means the 'p' word: profits.
Spot the flaw in the profit-driven approach to health care? Anyone?
Financial incentives?
When a pandemic isn't incentive enough -- I'd say we have another 'p' word -- a problem.